Isaksen Bjorn Andreas Freng Purchases 200,000 HSHP Shares
Insider buys HSHP shares worth $3.04 million.
Key Points
- Isaksen Bjorn Andreas Freng purchased 200,000 shares of HSHP on June 17, 2026, at $15.22 each, totaling $3.04 million.
- HSHP shares recently traded at $13.79, with peers like Goldman Sachs Group and Barclays PLC making notable share changes.
- Cleaves Securities downgraded HSHP to a sell with a $39 price target on September 18, 2023.
Isaksen Bjorn Andreas Freng made a significant insider purchase of HSHP shares on June 17, 2026. He acquired 200,000 shares at an average price of $15.22 each, amounting to a total transaction value of $3.04 million. This move was not part of a pre-planned trading program.
Other Institutional Activity in HSHP
Several institutional investors have adjusted their positions in HSHP. Goldman Sachs Group Inc. significantly increased its holdings by 1,618,402 shares, bringing its total to 1,878,361 shares valued at $24,982,201. Barclays PLC also made a substantial addition of 1,010,584 shares, ending with 1,271,364 shares worth $16,909,143. Meanwhile, FMR LLC added 1,110 shares, resulting in a total of 2,034,458 shares valued at $27,078,766. Hosking Partners LLP reduced its stake by 16,351 shares, leaving it with 1,878,074 shares valued at $24,978,384.
HSHP Stock Snapshot
HSHP shares recently traded around $13.79. The stock has seen various movements among institutional investors, indicating active interest. However, the current market dynamics and recent insider transactions could influence future trading.
Insider Buying and Selling at HSHP
In addition to Isaksen's recent purchase, he also sold 200,000 shares on the same day at $6.65. On May 22, 2026, Vidar Hasund, the Contracted CFO, sold 100,000 shares, while Carl Erik Steen bought 75,000 shares at $6.49. On the same day, Hasund also purchased 100,000 shares at $6.49.
Analysts Set New Price Targets
On September 18, 2023, Cleaves Securities downgraded HSHP to a sell rating and set a price target of $39. This reflects a cautious stance on the stock's future prospects amid recent market conditions.
Bottom Line
Isaksen Bjorn Andreas Freng's purchase of HSHP shares highlights an insider's confidence in the company. Institutional activity shows varied interest, with some funds significantly increasing their stakes. However, the recent downgrade by Cleaves Securities suggests mixed sentiments in the market. Investors should note that insider transactions and analyst ratings can provide insights but are not definitive indicators of future performance.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.